Cost-effectiveness of cardiomyopathy ambulatory care with sacubitril/valsartan vs standard therapy after COVID-19 in Kazakhstan

• Main Authors: Dana Dadanbekova (Author), Kairat Zhakipbekov (Author), Almat Kodasbayev (Author), Ubaidilla Datkhayev (Author), Guenka Petrova (Author), Konstantin Tachkov (Author)
• Format: Book
• Published: Pensoft Publishers, 2024-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The aim of this study is to evaluate the cost-effectiveness of 2 different therapies of cardiomyopathy (CM) after COVID -19. The focus of the study is fixed dose combination (FDC) of sacubitril/valsartan and standard therapy in Kazakhstan. This is written from the point of view of the health insuran...